ID: ALA1171971

Max Phase: Preclinical

Molecular Formula: C10H7Cl2NO2S2

Molecular Weight: 308.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=S(=O)(Nc1ccccc1)c1cc(Cl)sc1Cl

Standard InChI:  InChI=1S/C10H7Cl2NO2S2/c11-9-6-8(10(12)16-9)17(14,15)13-7-4-2-1-3-5-7/h1-6,13H

Standard InChI Key:  ILXABJHIVUDACG-UHFFFAOYSA-N

Associated Targets(non-human)

Protein kinase Pfmrk 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 308.21Molecular Weight (Monoisotopic): 306.9295AlogP: 3.86#Rotatable Bonds: 3
Polar Surface Area: 46.17Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.67CX Basic pKa: CX LogP: 3.78CX LogD: 3.18
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.94Np Likeness Score: -2.17

References

1. Caridha D, Kathcart AK, Jirage D, Waters NC..  (2010)  Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases.,  20  (13): [PMID:20627564] [10.1016/j.bmcl.2010.05.039]
2. Rotella DP..  (2012)  Recent results in protein kinase inhibition for tropical diseases.,  22  (22): [PMID:23063403] [10.1016/j.bmcl.2012.09.044]

Source